Clearmind Medicine Inc.
CMND· Nasdaq
CMNDClearmind Medicine Inc.
Who holds Clearmind Medicine Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 11.7K | New | $25.8K | 0% | Sep 2, 2026 |
| AdvisorShares Investments LLC | 1.2K | −84.1% | $2.6K | 0.1% | Aug 11, 2026 |
| Morgan Stanley | 700 | New | $1.5K | 0% | Aug 13, 2026 |
| Royal Bank of Canada | 287 | +1,950.0% | $1K | 0% | Aug 14, 2026 |
| HRT Financial LP | 35.1K | +120.9% | $77 | 0.1% | Aug 14, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | New | $2 | 0% | Aug 5, 2026 |
